HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martha Daviglus Selected Research

Martha Daviglus Research Topics

Disease

9Hypertension (High Blood Pressure)
12/2022 - 01/2018
6Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 11/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2018
3Cognitive Dysfunction
01/2022 - 01/2021
3Diabetes Mellitus
12/2021 - 05/2017
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2020 - 12/2015
2Heart Diseases (Heart Disease)
12/2021 - 06/2015
2Sleep Apnea Syndromes (Sleep Apnea)
12/2021 - 11/2018
2Obesity
01/2021 - 01/2018
2Non-alcoholic Fatty Liver Disease
01/2020 - 10/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 03/2003
1Inflammation (Inflammations)
01/2022
1Dementia (Dementias)
01/2022
1Heartburn (Pyrosis)
01/2021
1Hearing Loss (Hearing Impairment)
01/2021
1Chronic Renal Insufficiency
01/2020
1Arthritis (Polyarthritis)
01/2020
1Stroke (Strokes)
01/2020
1Genetic Risk Score
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Metabolic Diseases (Metabolic Disease)
01/2020
1Peripheral Arterial Disease
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2019
1Chronic Kidney Failure (Chronic Renal Failure)
11/2018
1Albuminuria
11/2018
1Sleepiness
10/2018
1Coronary Disease (Coronary Heart Disease)
01/2018
1Type 2 Diabetes Mellitus (MODY)
11/2016
1Dyslipidemias (Dyslipidemia)
11/2015
1Rheumatoid Arthritis
11/2015
1Atherosclerosis
08/2014
1Asthma (Bronchial Asthma)
01/2013

Drug/Important Bio-Agent (IBA)

13Polymethyl Methacrylate (Sol)IBA
12/2022 - 12/2015
5Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 06/2015
4HDL CholesterolIBA
01/2022 - 11/2015
4LipidsIBA
12/2021 - 11/2015
3LDL CholesterolIBA
12/2021 - 11/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 11/2015
3CholesterolIBA
12/2018 - 11/2015
2Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2021
2Biological ProductsIBA
01/2022 - 12/2021
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2021
2Transaminases (Aminotransferases)IBA
01/2020 - 10/2019
1C-Reactive ProteinIBA
01/2022
1Pharmaceutical PreparationsIBA
12/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1ApolipoproteinsIBA
01/2021
1AcidsIBA
01/2021
1LeptinIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2020
1Alanine Transaminase (SGPT)IBA
10/2019
1Protein Isoforms (Isoforms)IBA
12/2018
1Apolipoprotein E4IBA
12/2018
1CreatinineIBA
11/2018
1AlbuminsIBA
11/2018
1Caffeine (No Doz)FDA LinkGeneric
10/2018
1SodiumIBA
01/2018
1PotassiumIBA
01/2018
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018
1NitrogenIBA
06/2015
1Urea (Carbamide)FDA LinkGeneric
06/2015
1Particulate MatterIBA
08/2014
1Fatty Acids (Saturated Fatty Acids)IBA
01/2013
1CalciumIBA
03/2003

Therapy/Procedure

3Subacute Care
04/2021 - 01/2018
3Therapeutics
01/2020 - 06/2015
1Secondary Prevention
01/2020